Sign In
Buy TARS
Tarsus Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -33.06. In total, the insiders bought 847.4K and sold 221.95K TARS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-33.06 |
| ● Buy | 847.4K shares |
| ● Sell | 221.95K shares |
|
59% Buy Activity
Moderate Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Feb 18, 2026 Buy |
Pyott David E I Director |
0 Value: $0 |
||
|
Feb 18, 2026 Buy |
Pyott David E I Director |
5 893 Value: $372.9K |
||
|
Feb 18, 2026 Buy |
Pyott David E I Director |
3 729 Value: $235.9K |
||
|
Feb 18, 2026 Buy |
Pyott David E I Director |
2 128 Value: $106.3K |
||
|
Feb 18, 2026 Buy |
Pyott David E I Director |
2 500 Value: $45.7K |
||
|
Jan 02, 2026 Sell |
Whitfield Dianne C. Chief Human Resources Officer |
893 Value: $74.1K |
||
|
Jan 02, 2026 Sell |
Whitfield Dianne C. Chief Human Resources Officer |
8 122 Value: $655.5K |
||
|
Jan 02, 2026 Sell |
Whitfield Dianne C. Chief Human Resources Officer |
5 715 Value: $457.7K |
||
|
Jan 02, 2026 Sell |
Whitfield Dianne C. Chief Human Resources Officer |
835 Value: $68.4K |
||
|
Dec 24, 2025 Sell |
Azamian Bobak R. President/ceo And Board Chair |
557 Value: $46.5K |
||
|
Dec 24, 2025 Sell |
Azamian Bobak R. President/ceo And Board Chair |
5 443 Value: $448.6K |
||
|
Dec 16, 2025 Buy |
Neervannan Seshadri Chief Operating Officer |
475 Value: $37.2K |
||
|
Dec 16, 2025 Sell |
Neervannan Seshadri Chief Operating Officer |
950 Value: $0 |
||
|
Dec 16, 2025 Sell |
Whitfield Dianne C. Chief Human Resources Officer |
7 397 Value: $592.5K |
||
|
Dec 16, 2025 Sell |
Lin Elizabeth Yeu Chief Medical Officer |
2 078 Value: $165.2K |
||
|
Dec 15, 2025 Buy |
Goodrich Katherine Director |
2 233 Value: $179.8K |
||
|
Dec 15, 2025 Buy |
Goodrich Katherine Director |
2 233 Value: $179.8K |
||
|
Dec 15, 2025 Sell |
Link William J Phd Director |
5 046 Value: $407.7K |
||
|
Dec 15, 2025 Sell |
Link William J Phd Director |
4 766 Value: $388.4K |
||
|
Dec 15, 2025 Sell |
Link William J Phd Director |
1 148 Value: $94.6K |
||
|
Dec 15, 2025 Sell |
Link William J Phd Director |
6 306 Value: $515.5K |
||
|
Dec 15, 2025 Sell |
Link William J Phd Director |
5 680 Value: $458.4K |
||
|
Dec 15, 2025 Buy |
Lin Elizabeth Yeu Chief Medical Officer |
6 819 Value: $548.9K |
||
|
Dec 15, 2025 Buy |
Lin Elizabeth Yeu Chief Medical Officer |
6 819 Value: $548.9K |
||
|
Dec 04, 2025 Sell |
Azamian Bobak R. President/ceo And Board Chair |
51 885 Value: $0 |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
